1. Symposium: Detection and management of lower UTI — the value of single dose therapy. Munich, 19 November 1988

   • K. G. Naber

   UTIs: An Overview Pages: S33 - S33

2. Urinary infection in the 1990's: The state of the art

   • W. Brumfitt
   • J. M. T. Hamilton-Miller

   UTIs: An Overview Pages: S34 - S39

3. The epidemiology of urinary tract infection and the concept of significant bacteriuria

   • T. M. Hooton

   UTIs: An Overview Pages: S40 - S43

4. Natural history of “lower” urinary tract infections

   • C. M. Kunin

   UTIs: An Overview Pages: S44 - S49

5. The optimal management of lower urinary tract infections

   • L. E. Nicolle

   UTIs: An Overview Pages: S50 - S52

6. Review of published studies on single dose therapy of urinary tract infections

   • R. R. Bailey

   UTIs: An Overview Pages: S53 - S56

7. Fosfomycin trometamol: Historical background and clinical development

   • Giuliana Gialdroni Grassi

   Discussion 1 Fosfomycin Trometamol Preclinical Studies Pages: S57 - S59

8. Fosfomycin trometamol: Activity in vitro against urinary tract pathogens

   • D. Greenwood

   Discussion 1 Fosfomycin Trometamol Preclinical Studies Pages: S60 - S64

9. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity

   • T. Bergan

   Discussion 1 Fosfomycin Trometamol Preclinical Studies Pages: S65 - S69

10. Fosfomycin trometamol versus ofloxacin/Co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: A multicentre study

    • K. G. Naber
    • U. Thyroff-Friesinger

    Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S70 - S76

11. Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice

    • J. Reynaert
    • D. Van Eyck
    • J. Vandepitte

    Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S77 - S79

12. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice

    • J. B. J. Boerema
    • F. Th. C. Willems

    Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S80 - S88

13. A general practitioner multicenter study: Fosfomycin trometamol single dose versus pipemidic acid multiple dose

    • A. Jardin

    Discussion 2 Fosfomycin Trometamol International Clinical Studies Pages: S89 - S93

14. Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: Preliminary results

    • H. Thoumsin
    • M. Aghayan
    • R. Lambotte

    Comparative Trials in Special Population Patients Pages: S94 - S97

15. Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manœuvres. Results of a multicentre study

    • F. di Silverio
    • G. Ferrone
    • L. Carati

    Comparative Trials in Special Population Patients Pages: S98 - S102

16. Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection

    • L. Baert
    • I. Billiet
    • J. Vandepitte

    Comparative Trials in Special Population Patients Pages: S103 - S106

17. An open study of the efficacy and safety of single dose fosfomycin trometamol in treatment of hospitalised patients with urinary tract infection (pilot study)

    • A. P. MacGowan
    • R. A. Bailey
    • D. S. Reeves

    Comparative Trials in Special Population Patients Pages: S107 - S108

18. Symposium: Detection and management of lower UTIs — The value of single dose therapy. Munich, 19 November 1988

    • K. G. Naber

    Summary Of Discussions And Closing Remarks Pages: S109 - S112